Head-to-head · Cost-Efficiency Index
Ondra Health vs MyDrHank
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Ondra Health
Value shoppers who want one of the lowest disclosed prices on both molecules without giving up nationwide access or pharmacy verification.
Visit Ondra HealthMyDrHank
Needle-averse shoppers who want a daily semaglutide tablet, have decided a twelve-month commitment is acceptable, and value a price that never moves as the dose climbs more than a low sticker.
Visit MyDrHankThe verdict
Ondra Health takes it, leading the Cost-Efficiency Index 90 to 65. A rare combination — near-rock-bottom pricing on both molecules, all-50 access, brand-name availability, and a LegitScript-verified pharmacy behind it. MyDrHank still earns a C — Needle-averse shoppers who want a daily semaglutide tablet, have decided a twelve-month commitment is acceptable, and value a price that never moves as the dose climbs more than a low sticker.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Ondra Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Ondra Health | MyDrHank |
|---|---|---|
| Cost-Efficiency Index | 90/100 | 65/100 |
| Semaglutide / mo | $93/mo | $249/mo oral, $259/mo injectable (yearly prepay: $171 / $178) |
| Tirzepatide / mo | $166/mo | $349/mo month-to-month ($240/mo only on a year prepaid) |
| Semaglutide / yr (modeled) | $1,116 | $2,988 |
| Tirzepatide / yr (modeled) | $1,992 | $4,188 |
| Coverage | All 50 states | Not published; program excludes KS, LA, MS, NM, ND, WV |
| Oral / sublingual | No | Yes |
| Brand-name access | Yes | Compounded only |
| Rank on the board | #2 | #108 |
Ondra Health
90/100Where the value is
- Among the lowest disclosed prices on the board — $93 semaglutide and $166 tirzepatide
- Available in all 50 states with both molecules published for clean cost modeling
- LegitScript-certified, and offers FDA-approved brand-name access alongside compounded
The tradeoffs
- A newer, lower-profile operator without CoreAge's long flat-price track record
- No oral/sublingual route
MyDrHank
65/100Where the value is
- The price does not change as your dose is titrated up — its FAQ states it plainly ("The price stays the same at every dose — no surprise price increases"), and dose-indexed pricing is the single most common way a cheap first month becomes an expensive fourth one
- A genuine oral route on semaglutide: a daily tablet, including one compounded with low-dose ondansetron specifically to blunt the nausea that ends most GLP-1 courses early
- The entire price ladder is public — monthly, quarterly, 6-month and yearly, with the total for each term printed beside the per-month figure — before any quiz, intake or email capture
The tradeoffs
- EVERY price the site advertises is a twelve-month prepay rate, and not by accident: the price display is coded to return the cheapest term in the ladder, so "From $X/mo" is always the yearly figure. No page shows a month-to-month rate beside it
- What the twelve months actually cost, up front: oral semaglutide $2,057 to reach the advertised $171/mo, injectable semaglutide $2,140 to reach $178/mo, and tirzepatide $2,883 to reach $240/mo
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.